1. ScholarBank@NUS

Seng Gee Lim

rp00481

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Seng Gee Lim
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
Faculty
 
Email
mdclimsg@nus.edu.sg
 

Publications

Results 81-100 of 109 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
812004Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A proteinChoi, Y.-W.; Tan, Y.-J.; Lim, S.G. ; Hong, W. ; Goh, P.-Y.
822007Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.Zhang, D. ; Lim, S.G. ; Koay, E.S. 
83Jul-2022Quantitative HBsAg (qHBsAg) as an end point to stop nucleos (t) ide analogues in chronic hepatitis B: a meta-analysis with meta-regressionLim, Seng Gee ; Der Teo, Ada Ee; Chan, Edwin Shih-Yen; Phyo, Wah Wah ; Yu Chen, David Hsing; Hargreaves, Carol Anne 
842008Rac1 GTPase is activated by hepatitis B virus replication - involvement of HBXTan, T.L.; Fang, N.; Zhang, J.; Chan, V.; Chen, W.N.; Neo, T.L.; Singh, P.; Zhou, R.; Koh, C.-G.; Lim, S.G. 
852006Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis BLim, S.G. ; Krastev, Z.; Ng, T.M.; Mechkov, G.; Kotzev, I.A.; Chan, S.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
86Jan-2014Reduction of HBV replication prolongs the early immunological response to IFNα therapyTan, A.T.; Hoang, L.T.; Chin, D.; Rasmussen, E.; Lopatin, U.; Hart, S.; Bitter, H.; Chu, T.; Gruenbaum, L.; Ravindran, P.; Zhong, H.; Gane, E.; Lim, S.G. ; Chow, W.C.; Chen, P.-J.; Petric, R.; Bertoletti, A. ; Hibberd, M.L.
872006Referral patterns and waiting times for liver transplantation in SingaporeLim, S.G. ; Wai, C.T. ; Sutedja, D.S.; Lee, Y.M. ; Da, Costa M.; Lee, K.H. ; Aw, M.M. ; Quak, S.H. ; Prabhakaran, K. ; Isaac, J. ; Tan, C.K.
882010Reliability and validity of a Chinese version's health-related quality of life questionnaire for hepatitis B patientsOng, S.C.; Lim, S.G. ; Li, S.C. 
89Sep-2011Risk factors for mortality in cirrhotic patients with sepsisLim, L.-G.; Tan, X.-X.E.; Woo, S.-J.; Dan, Y.-Y. ; Lee, Y.-M.; Lai, V.; Lim, S.-G. 
901-Jan-2019Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infectionLow, EXS; Tripon, E; Lim, K0; Tan, PS ; Low, HC ; Dan, YY ; Lee, YM ; Muthiah, M ; Loo, WM ; Koh, CJ ; Phyo, WW ; Pang, JX; Lim, SG ; Lee, GH 
912017Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic historyZhu, Y.O; Aw, P.P.K; de Sessions, P.F; Hong, S; See, L.X; Hong, L.Z; Wilm, A; Li, C.H; Hue, S; Lim, S.G ; Nagarajan, N ; Burkholder, W.F; Hibberd, M 
922003Successful treatment of Xylohypha bantiana brain abscess mimicking invasive cerebral aspergillosis in a liver transplant recipientLee, Y.M. ; Tambyah, P.A. ; Lee, K.H. ; Lim, S.G. ; Tan, K.C.
932006Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsChen, Y.; Kong, K.H. ; Ang, T.H.; Lam, Y. ; Tan, T.M.C. ; Bai, J.; Li, Y. ; Lim, S.G. 
942006Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsChen, Y. ; Kong, K.H.; Ang, T.H.; Lam, Y. ; Tan, T.M.C. ; Bai, J. ; Li, Y.; Lim, S.G. 
952015Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyMarcellin Patrick; Wursthorn Karsten; Wedemeyer Heiner; Chuang Wan Long; Lau George; Avila Claudio; Peng Cheng Yuan; Gane Edward; Lim Seng Gee ; Fainboim Hugo; Foster Graham R.; Safadi Rifaat; Rizzetto Mario; Manns Michael; Bao Webin; Trylesinski Aldo; Naoumov Nikolai
962008Telbivudine: A hepatitis B-specific antiviralLim, S.G. 
972000Ten years of experience of liver transplantation in SingaporeWai, C.T. ; Lo, S.K.; Lee, K.H. ; Tan, C.K. ; Aw, M.M. ; Quak, S.H. ; Isacc, J.; Prabhakaran, K. ; Lim, S.G. ; Tan, K.C.
982001The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavageGoh, P.-Y.; Tan, Y.-J.; Lim, S.P.; Lim, S.G. ; Tan, Y.H. ; Hong, W.J. 
992007The level of viral antigen presented by hepatocytes influences CD8 T-cell functionGehring, A.J.; Kennedy, P.T.F.; Selden, C.; Bertoletti, A. ; Sun, D.; Nassal, M.; Nolte-'T, Hoen E.; Davis, D.M.; Lim, S.G. ; Wasser, S. ; Maini, M.K.
1002004The majority of hepatitis B carriers are not on regular surveillance in SingaporeWai, C.-T.; Mak, B.; Chua, W.; Lim, S.G.